About this policy
The comment period for the MolDX: EndoPredict® Breast Cancer Gene Expression Test (LCD) L37311 began on 06/01/2017 and ended on 08/14/2017. Comments were received from the provider community. The notice period begins on 12/14/2017 and ends 01/29/2018. The LCD becomes final on 01/30/2018.
Codes in this policy
Code numbers and each code’s status as the policy records it. CPT code descriptions are left out of this page, as are the passages that cite CPT codes; the official document has them.
Backwork has no codes on record for this policy. Check the source.